PLEASE TELL US A LITTLE ABOUT YOURSELF SO THAT WE CAN DISPLAY THE MOST
APPROPRIATE CONTENT TO YOU:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies used on Trustnet and how you can manage them, see our Privacy and Cookie Policy.

By clicking "I Agree" below, you acknowledge that you accept our Privacy Policy and Terms of Use.

For more information Click here

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
Share   Print      RSS

Integumen PLC (SKIN)

Integumen PLC

Exercise of Warrants; Total Voting Rights
RNS Number : 1131W
Integumen PLC
14 August 2020
 

AIM share code: SKIN

14 August 2020

 

Integumen PLC

 

("Integumen" or "Company")

 

 

Exercise of Warrants  

 

Integumen announces that it has received notification from multiple warrant holders to exercise warrants over 29,404,762 shares in the share capital of Integumen ("the Warrant Shares"). This consists of 26,071,429 warrants with an exercise price of 2 pence and 3,333,333 warrants with an exercise price of 1.5 pence. T he consideration for the exercise of the Warrant Shares amounts, in aggregate, to a cash value of   £571,428.57.

 

Gerard Brandon Chief Executive Officer of Integumen commented:

"The largest institutional shareholder, Helium Rising Stars Fund, who currently hold 7.3% of Integumen shares are exercising 60% of the above warrants which will increase their holding to 8.7%. We are grateful for their continued confidence in the future growth of the Company"

 

Total voting rights

 

The Warrant Shares were allotted on 13 August 2020. Application has been made for the 29,404,762 Warrant Shares to be admitted to trading on AIM ("Admission"), and Admission is expected to be on or about 19 August 2020. These shares will rank pari passu with the ordinary shares of the Company in issue.

 

The Company's total issued share capital following the issue of the Warrant Shares will be 1,109,870,711 ordinary shares. As the Company does not hold any shares in Treasury, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.

 

 

Integumen plc

Gerard Brandon, CEO

+44 (0) 7340 055 648

 

 

 

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

 

 

 

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/Zoe Alexander

+44 (0) 20 3657 0050

 

 

 

 

About Integumen plc:

Integumen is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFLFLATTIVLII
Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

You are currently using an old browser which will not be supported by Trustnet after 31/07/2016. To ensure you benefit from all features on the site, please update your browser.   Close